BDBM436101 4-(((3S,4R)-1- ((5-chloropyridin- 2-yl)sulfonyl)-4- hydroxy-4- (hydroxymethyl) pyrrolidin-3-yl) methyl)-3-(2,2,2- trifluoroethoxy) benzonitrile::US10590077, Example 3

SMILES OC[C@]1(O)CN(C[C@@H]1Cc1ccc(cc1OCC(F)(F)F)C#N)S(=O)(=O)c1ccc(Cl)cn1

InChI Key InChIKey=OONSVANWVUSFKJ-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 436101   

TargetTransient receptor potential cation channel subfamily V member 4(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM436101(US10590077, Example 3 | 4-(((3S,4R)-1- ((5-chlorop...)
Affinity DataIC50: 55nMAssay Description:TRPV4 channel activation results in an influx of divalent and monovalent cations including calcium. The resulting changes in intracellular calcium we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
Go to US Patent